Access cutting-edge platinum-resistant ovarian cancer treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Little Rock location
Preparing your pre-screening questions…
Access platinum-resistant ovarian cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related platinum-resistant ovarian cancer treatment provided free
Check if you qualify for this platinum-resistant ovarian cancer clinical trial in Little Rock, AR
No-Cost Study Care
Local to Little Rock
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific antibody , in participants with platinum-refractory/resistant ovarian cancer (PRROC) and other advanced CLDN6-positive solid tumors (i.e., testicular and endometrial).
Sponsor: Context Therapeutics Inc.
Yes, this clinical trial (NCT06515613) has an active research site in Little Rock, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for platinum-resistant ovarian cancer treatment options in Little Rock, AR, this clinical trial (NCT06515613) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced platinum-resistant ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all platinum-resistant ovarian cancer clinical trials near you to find additional studies recruiting in your area.
See all ovarian cancer clinical trials recruiting in Little Rock — not just this study.
Browse Ovarian Cancer Trials in Little Rock →